X4 Pharmaceuticals, Inc. - Common Stock (XFOR)
2.9000
-0.0300 (-1.02%)
NASDAQ · Last Trade: Aug 14th, 5:11 AM EDT
These stocks have an unusual volume in today's session
Via Chartmill · August 13, 2025
The company said that the originally announced offering of $60 million was increased to $85 million to allow for the inclusion of an investor who had a pre-existing investment right.
Via Stocktwits · August 13, 2025
Via Benzinga · August 13, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · August 12, 2025
Via Benzinga · August 12, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · August 12, 2025
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · August 12, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · August 12, 2025
Via Benzinga · August 12, 2025
Via Benzinga · July 24, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · July 24, 2025
Via Benzinga · July 24, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
Via Chartmill · July 24, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via Chartmill · April 24, 2025
Via Benzinga · April 24, 2025
Via Benzinga · April 17, 2025
Via Benzinga · March 27, 2025

Via Benzinga · January 30, 2025

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.
Via Benzinga · June 24, 2024